Viewing nowCombinationTelmitwin Tablets 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
(Ltd.) Hanpung Pharmaceutical

MFDS item code 201905315 · Approved 2019.07.26 · Insurance code 658106770
Improvement in blood pressure control for essential hypertension.
This medication effectively lowers blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan. Managing essential hypertension is crucial for preventing cardiovascular diseases, and this medication helps stabilize blood pressure. It acts by combining two components that dilate blood vessels and reduce blood pressure, making it suitable for patients with poorly controlled blood pressure. It plays an important role in improving overall cardiovascular health and aids in blood pressure management.
The recommended dosage of this medication is 1 tablet once daily and should be taken with water, regardless of meals. It is advised to take it at the same time every day (e.g., in the morning) if possible. For patients whose blood pressure is not adequately controlled, adjustments in dosage should be made individually. Caution and dosage adjustments are necessary for patients with kidney impairment, liver impairment, and elderly patients.
Safety and efficacy for pediatric patients under 18 years have not been established, so administration of this medication is not recommended.
This medication should not be used during pregnancy, particularly in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, the use of this medication must be discontinued immediately. Patients with hypersensitivity to this medication or with specific heart, liver, or kidney diseases should not take it. It is also advisable for nursing mothers to avoid using this medication. Patients with severe liver disease or heart problems should use this medication cautiously and may require dose adjustments. It should not be administered to patients with significantly low blood pressure or in shock. Caution is needed for patients with diabetes or severe kidney impairment, especially when combined with other medications. Side effects such as dizziness and peripheral edema may occur during treatment, so caution is necessary. Due to the blood pressure-lowering effects, patients should be careful when driving or operating machinery as drowsiness or dizziness may occur. There is a risk of hyperkalemia, so periodic monitoring of potassium levels is recommended. Co-administration with other antihypertensives may result in hypotension or changes in kidney function, thus following the physician's instructions is essential. It is recommended to avoid taking this medication with grapefruit juice as it may enhance the drug's effects. In case of overdose, severe hypotension or heart problems can occur, so the dosage must be strictly adhered to. Special caution is necessary when administering this medication to children or elderly patients; for elderly patients, the dosage should be adjusted slowly. Store this medication in a place out of reach of children, and it is advisable to take it immediately after opening.
Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, liver abnormalities (jaundice), sudden and severe headache, thunderclap headache.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly sealed container that blocks light. It is crucial to maintain a storage temperature between 1°C and 30°C in order to preserve the drug's effectiveness and safety.
A biconvex oval double tablet that is white and light gray.
30 tablets/PTP [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
(Ltd.) Hanpung Pharmaceutical
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.